Semarion
Microfabricated, barcoded cell microcarriers for pharmaceutical and biotech teams running adherent-cell assays
Highlights
- New on EvolcAdded 2026-11-14
About Semarion
Semarion develops SemaCyte® microcarriers: barcoded micro-wells that carry adherent cell colonies in a uniform geometry. They can be handled with standard liquid-handling systems, oriented magnetically, cryopreserved, and used to multiplex cell models in automated assay workflows.
The platform is designed for drug-discovery teams using engineered, primary, or patient-derived cell models. Cambridge-based Semarion was founded in 2018 and develops and manufactures its microcarriers using microfabrication techniques.
Product: SemaCyte® barcoded microcarriers for handling, cryopreserving, and multiplexing adherent cells in drug-discovery assays.
Jobs at Semarion
Leadership
- Jeroen Verheyen · Co-Founder & Chief Executive OfficerSource: company website
- Tarun Vemulkar · Co-Founder & Chief Technology OfficerSource: company website
More biotech & pharma companies
Senisca
Develops RNA-based therapies targeting cellular ageing for patients with age-related diseasesNew on EvolcSENTINAL4D
AI models and imaging data tools for biotech and pharmaceutical R&D teams studying cell morphology and drug responsesYoung companyNew on EvolcSequoia Genetics
Human genetics research and analysis for pharma, biotech, investors, and academic institutions developing medicinesYoung companyNew on EvolcSeren Plus
Wholesale supplier of prescription medicines and aesthetic products to pharmacies and clinics across the UKShafi Consultancy
Clinical trial statistical programming and data services for pharmaceutical companies and contract research organizationsNew on EvolcSiinovia (UK)
Develops and distributes niche generic and value-added medicines for healthcare markets and pharmaceutical partnersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.